Xiangdong Guan

5PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesIntensive careMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 15, 2025
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.

Jianfeng Wu, Fei Pei, Lixin Zhou

|Jan 12, 2025
Comparison of the efficacy and safety of Landiolol and Esmolol in critically ill patients: a propensity score-matched study.

Xiang Si, Hao Yuan, Rui Shi

|Oct 25, 2024
Early sedation using ciprofol for intensive care unit patients requiring mechanical ventilation: a pooled post-hoc analysis of data from phase 2 and phase 3 trials.

Yongjun Liu, Lingyun Zuo, Xiaoyun Li

|Jun 10, 2024
Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China.

Lingyun Zuo, Xiaoyun Li, Luhao Wang

|Nov 17, 2020
Upregulation of the microRNA rno-miR-146b-5p may be involved in the development of intestinal injury through inhibition of Kruppel-like factor 4 in intestinal sepsis.

Li Tong, Chaoxia Tang, Changjie Cai

Pageof 1

Frequent Collaborators

1 joint publications

Yongjun Liu